Vision Loss in Giant Cell Arteritis Treated With Tocilizumab Vision Loss in Giant Cell Arteritis Treated With Tocilizumab

A new study examines the incidence of vision loss among patients with giant cell arteritis during treatment with tocilizumab compared with conventional glucocorticoid therapy.Arthritis Research & Therapy
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news